Galera Therapeutics files to implement 1-for-200 reverse stock split

Galera Therapeutics filed a certificate of amendment to effect a 1-for-200 reverse stock split effective July 12, 2026. Shareholders will receive cash in lieu of fractional shares based on the last trading price before the split.